Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
- View all (145)
- Volume 8, 2021 (18)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- 145 records -
NAFLD-Associated HCC: Progress and Opportunities
Geh D, Anstee QM, Reeves HL
Journal of Hepatocellular Carcinoma 2021, 8:223-239
Published Date: 8 April 2021
High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma
Guo X, Tian S, Cao P, Xie Y, Dong W
Journal of Hepatocellular Carcinoma 2021, 8:211-222
Published Date: 6 April 2021

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
Weng J, Zhou C, Zhou Q, Chen W, Yin Y, Atyah M, Dong Q, Shi Y, Ren N
Journal of Hepatocellular Carcinoma 2021, 8:193-209
Published Date: 29 March 2021
The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges
D'Alessio A, Prete MG, Cammarota A, Personeni N, Rimassa L
Journal of Hepatocellular Carcinoma 2021, 8:177-191
Published Date: 29 March 2021
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Mei J, Li SH, Li QJ, Sun XQ, Lu LH, Lin WP, Zheng L, Chen MS, Shi M, Wei W, Guo RP
Journal of Hepatocellular Carcinoma 2021, 8:167-176
Published Date: 25 March 2021
Short- and Long-Term Outcomes After Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 229 Cases from a Developing Country
Galun D, Bogdanovic A, Zivanovic M, Zuvela M
Journal of Hepatocellular Carcinoma 2021, 8:155-165
Published Date: 23 March 2021
Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials
Park R, Lopes da Silva L, Nissaisorakarn V, Riano I, Williamson S, Sun W, Saeed A
Journal of Hepatocellular Carcinoma 2021, 8:145-154
Published Date: 22 March 2021
Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections
Gül-Klein S, Kästner A, Haber PK, Krenzien F, Wabitsch S, Krannich A, Andreou A, Eurich D, Tacke F, Horst D, Pratschke J, Schmelzle M
Journal of Hepatocellular Carcinoma 2021, 8:133-143
Published Date: 18 March 2021
A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
Wang Z, Embaye KS, Yang Q, Qin L, Zhang C, Liu L, Zhan X, Zhang F, Wang X, Qin S
Journal of Hepatocellular Carcinoma 2021, 8:119-132
Published Date: 16 March 2021

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)
Liang L, Wang MD, Zhang YM, Zhang WG, Zhang CW, Lau WY, Shen F, Pawlik TM, Huang DS, Yang T
Journal of Hepatocellular Carcinoma 2021, 8:103-118
Published Date: 12 March 2021
Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
Chang X, Lv YF, He J, Cao Y, Li CQ, Guo QN
Journal of Hepatocellular Carcinoma 2021, 8:85-101
Published Date: 12 March 2021
Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model
Mauda-Havakuk M, Mikhail AS, Starost MF, Jones EC, Karim B, Kleiner DE, Partanen A, Esparza-Trujillo JA, Bakhutashvili I, Wakim PG, Kassin MT, Lewis AL, Karanian JW, Wood BJ, Pritchard WF
Journal of Hepatocellular Carcinoma 2021, 8:71-83
Published Date: 9 March 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ
Journal of Hepatocellular Carcinoma 2021, 8:57-69
Published Date: 3 March 2021
Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
Shi T, Kobara H, Oura K, Masaki T
Journal of Hepatocellular Carcinoma 2021, 8:45-55
Published Date: 11 February 2021
Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis
Kim K, Kim TH, Kim TH, Seong J
Journal of Hepatocellular Carcinoma 2021, 8:35-44
Published Date: 11 February 2021
The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma
Li S, Xu W, Liao M, Zhou Y, Weng J, Ren L, Yu J, Liao W, Huang Z
Journal of Hepatocellular Carcinoma 2021, 8:23-33
Published Date: 9 February 2021
Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
Liu Q, Dong X
Journal of Hepatocellular Carcinoma 2021, 8:19-21
Published Date: 28 January 2021
Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
Ely A, Bloom K, Maepa MB, Arbuthnot P
Journal of Hepatocellular Carcinoma 2021, 8:1-17
Published Date: 27 January 2021
Effect of Inhibiting Tumor Angiogenesis After Embolization in the Treatment of HCC with Apatinib-Loaded p(N-Isopropyl-Acrylamide-co-Butyl Methyl Acrylate) Temperature-Sensitive Nanogel
Zhou C, Shi Q, Liu J, Huang S, Yang C, Xiong B
Journal of Hepatocellular Carcinoma 2020, 7:447-456
Published Date: 31 December 2020
Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right Atrium
Lee HA, Rim CH
Journal of Hepatocellular Carcinoma 2020, 7:435-446
Published Date: 21 December 2020
Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion
Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, Galle PR
Journal of Hepatocellular Carcinoma 2020, 7:423-433
Published Date: 21 December 2020
Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma
Zong J, Fan Z, Zhang Y
Journal of Hepatocellular Carcinoma 2020, 7:413-422
Published Date: 18 December 2020

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK
Journal of Hepatocellular Carcinoma 2020, 7:403-412
Published Date: 17 December 2020
Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant
Teng CF, Li TC, Wang T, Wu TH, Wang J, Wu HC, Shyu WC, Su IJ, Jeng LB
Journal of Hepatocellular Carcinoma 2020, 7:385-401
Published Date: 17 December 2020
Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?
Sun X, Hu D, Zhang Y, Lyu N, Xu L, Chen Q, Lai J, Chen M, Zhao M
Journal of Hepatocellular Carcinoma 2020, 7:377-384
Published Date: 16 December 2020
Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma
Li M, Hu J, Jin R, Cheng H, Chen H, Li L, Guo K
Journal of Hepatocellular Carcinoma 2020, 7:361-376
Published Date: 8 December 2020
Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC
Gao X, Zhan M, Wang L, Ding Y, Niu J
Journal of Hepatocellular Carcinoma 2020, 7:347-360
Published Date: 1 December 2020
Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy
Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y
Journal of Hepatocellular Carcinoma 2020, 7:337-345
Published Date: 1 December 2020
Value of Follow-Up Chest Computed Tomography in the Surveillance of Patients with Hepatocellular Carcinoma
Moawad AW, Elsayes KM, Benamar F, Rao K, Sun J, Szklaruk J
Journal of Hepatocellular Carcinoma 2020, 7:331-335
Published Date: 18 November 2020
Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma
Hu B, Yang XB, Sang XT
Journal of Hepatocellular Carcinoma 2020, 7:315-330
Published Date: 11 November 2020
Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients
Jensen C, Holm Nielsen S, Eslam M, Genovese F, Nielsen MJ, Vongsuvanh R, Uchila R, van der Poorten D, George J, Karsdal MA, Leeming DJ, Willumsen N
Journal of Hepatocellular Carcinoma 2020, 7:301-313
Published Date: 9 November 2020
Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors
Chen S, Huang Z, Jia W, Tao H, Zhang S, Ma J, Liu Z, Wang J, Wang L, Cui P, Zhang Z, Huang D, Wu Z, Zheng X, Hu Y
Journal of Hepatocellular Carcinoma 2020, 7:289-299
Published Date: 2 November 2020
Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C
Journal of Hepatocellular Carcinoma 2020, 7:271-288
Published Date: 29 October 2020
miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation
Tang J, Xiao XQ, Jiang Y, Tian Y, Peng Z, Yang M, Xu Z, Gong G
Journal of Hepatocellular Carcinoma 2020, 7:257-269
Published Date: 29 October 2020
Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management
Xu W, Liu F, Shen X, Li R
Journal of Hepatocellular Carcinoma 2020, 7:233-256
Published Date: 27 October 2020
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients
Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, Niu J
Journal of Hepatocellular Carcinoma 2020, 7:219-232
Published Date: 23 October 2020
Assessing the Survival Benefit of Surgery and Various Types of Radiation Therapy for Treatment of Hepatocellular Carcinoma: Evidence from the Surveillance, Epidemiology, and End Results Registries
Shi F, Wang C, Kong Y, Yang L, Li J, Zhu G, Guo J, Zheng Q, Zhang B, Wang S
Journal of Hepatocellular Carcinoma 2020, 7:201-218
Published Date: 19 October 2020
Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study
Lu L, Zhang Y, Zheng P, Wu Z, Wang X, Chen Y, Chen X
Journal of Hepatocellular Carcinoma 2020, 7:191-199
Published Date: 15 October 2020
Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
Kobayashi S, Tajiri K, Murayama A, Entani T, Futsukaichi Y, Nagata K, Takahashi K, Yasuda I
Journal of Hepatocellular Carcinoma 2020, 7:181-189
Published Date: 14 October 2020
The Clinicopathological and Imaging Characteristics of Primary Hepatic Carcinosarcoma and a Review of the Literature
Bin F, Chen Z, Liu P, Liu J, Mao Z
Journal of Hepatocellular Carcinoma 2020, 7:169-180
Published Date: 13 October 2020
Amide Proton Transfer Imaging vs Diffusion Kurtosis Imaging for Predicting Histological Grade of Hepatocellular Carcinoma
Wu B, Jia F, Li X, Zhang M, Han D, Jia Z
Journal of Hepatocellular Carcinoma 2020, 7:159-168
Published Date: 9 October 2020
Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization
Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN
Journal of Hepatocellular Carcinoma 2020, 7:155-158
Published Date: 28 September 2020
Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO
Journal of Hepatocellular Carcinoma 2020, 7:143-153
Published Date: 16 September 2020
Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
Raybould AL, Sanoff H
Journal of Hepatocellular Carcinoma 2020, 7:133-142
Published Date: 15 September 2020
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC
Journal of Hepatocellular Carcinoma 2020, 7:117-131
Published Date: 14 September 2020
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
Campani C, Bensi C, Milani S, Galli A, Tarocchi M
Journal of Hepatocellular Carcinoma 2020, 7:107-116
Published Date: 30 July 2020
Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation
Ren A, Li Z, Zhang X, Deng R, Ma Y
Journal of Hepatocellular Carcinoma 2020, 7:101-106
Published Date: 7 July 2020
Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations
Debaillon Vesque A, Decraecker M, Blanc JF
Journal of Hepatocellular Carcinoma 2020, 7:91-99
Published Date: 9 June 2020
Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging
Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM
Journal of Hepatocellular Carcinoma 2020, 7:77-89
Published Date: 23 April 2020
Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
Dash S, Aydin Y, Widmer KE, Nayak L
Journal of Hepatocellular Carcinoma 2020, 7:45-76
Published Date: 15 April 2020
Rare Site Hepatocellular Carcinoma Metastasis
Boldo E, Santafe A, Mayol A, Lozoya R, Coret A, Escribano D, Fortea-Sanchis C, Muñoz A, Pastor JC, Perez de Lucia G, Bosch N
Journal of Hepatocellular Carcinoma 2020, 7:39-44
Published Date: 25 March 2020

Impact of Next-Generation Sequencing on Outcomes in Hepatocellular Carcinoma: How Precise Are We Really?
Dominguez DA, Wang XW
Journal of Hepatocellular Carcinoma 2020, 7:33-37
Published Date: 19 March 2020
Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
Liu T, Li S, Wu L, Yu Q, Li J, Feng J, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C
Journal of Hepatocellular Carcinoma 2020, 7:19-31
Published Date: 18 February 2020
The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma
Singh P, Toom S, Avula A, Kumar V, Rahma OE
Journal of Hepatocellular Carcinoma 2020, 7:11-17
Published Date: 10 February 2020
Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction
Dumenci OE, U AMR, Khan SA, Holmes E, Taylor-Robinson SD
Journal of Hepatocellular Carcinoma 2020, 7:1-9
Published Date: 7 January 2020

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves


El Kassas M, Tawheed A, Eltabbakh M, Kaseb A
Journal of Hepatocellular Carcinoma 2019, 6:183-191
Published Date: 19 November 2019
Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida
Jones PD, Scheinberg AR, Muenyi V, Gonzalez-Diaz J, Martin PM, Kobetz E
Journal of Hepatocellular Carcinoma 2019, 6:167-181
Published Date: 15 November 2019
Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T, Liu M, Han J, Li Z, Chen S
Journal of Hepatocellular Carcinoma 2019, 6:151-166
Published Date: 18 October 2019

Hepatitis B And Hepatitis C Viral Infections And Associated Factors Among Patients With Diabetes Visiting Gondar Referral Teaching Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study
Million Y, Teklu T, Alemu S, Ferede A, Belachew T, Desta K
Journal of Hepatocellular Carcinoma 2019, 6:143-150
Published Date: 8 October 2019
Status of, and strategies for improving, adherence to HCC screening and surveillance
Francica G, Borzio M
Journal of Hepatocellular Carcinoma 2019, 6:131-141
Published Date: 24 July 2019
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma
Zakka K, Jiang R, Alese OB, Shaib WL, Wu C, Wedd JP, Sellers MT, Behera M, El-Rayes BF, Akce M
Journal of Hepatocellular Carcinoma 2019, 6:119-129
Published Date: 22 July 2019
Intermediate stage hepatocellular carcinoma: a summary review
Elshaarawy O, Gomaa A, Omar H, Rewisha E, Waked I
Journal of Hepatocellular Carcinoma 2019, 6:105-117
Published Date: 11 July 2019
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK
Journal of Hepatocellular Carcinoma 2019, 6:93-103
Published Date: 17 June 2019

Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma


Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML
Journal of Hepatocellular Carcinoma 2019, 6:85-91
Published Date: 6 June 2019
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
Lu LC, Chang CJ, Hsu CH
Journal of Hepatocellular Carcinoma 2019, 6:71-84
Published Date: 7 May 2019

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB
Journal of Hepatocellular Carcinoma 2019, 6:49-69
Published Date: 5 February 2019
Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK
Journal of Hepatocellular Carcinoma 2019, 6:41-48
Published Date: 31 January 2019
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
Personeni N, Pressiani T, Rimassa L
Journal of Hepatocellular Carcinoma 2019, 6:31-39
Published Date: 31 January 2019
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
Geh D, Rana FA, Reeves HL
Journal of Hepatocellular Carcinoma 2019, 6:23-30
Published Date: 14 January 2019

Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
Stavraka C, Rush H, Ross P
Journal of Hepatocellular Carcinoma 2019, 6:11-21
Published Date: 28 December 2018
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M
Journal of Hepatocellular Carcinoma 2019, 6:1-10
Published Date: 21 December 2018
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I
Journal of Hepatocellular Carcinoma 2018, 5:109-119
Published Date: 19 November 2018

Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist
Quaglia A
Journal of Hepatocellular Carcinoma 2018, 5:99-108
Published Date: 8 November 2018
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
Gilabert M, Raoul JL
Journal of Hepatocellular Carcinoma 2018, 5:91-98
Published Date: 2 November 2018
Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)
de Jesus VHF, Dettino ALA
Journal of Hepatocellular Carcinoma 2018, 5:87-90
Published Date: 3 October 2018


Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer


Dandachi D, Hassan M, Kaseb A, Angelidakis G, Torres HA
Journal of Hepatocellular Carcinoma 2018, 5:81-86
Published Date: 2 August 2018
Hepatocellular cancer pain: impact and management challenges
Christian-Miller N, Frenette C
Journal of Hepatocellular Carcinoma 2018, 5:75-80
Published Date: 19 July 2018

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM
Journal of Hepatocellular Carcinoma 2018, 5:61-73
Published Date: 27 June 2018
Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

Griffith AS, Hayashi PH, Burke LMB, McRee AJ
Journal of Hepatocellular Carcinoma 2018, 5:55-59
Published Date: 31 May 2018
Editorial: charting the future of hepatocellular carcinoma publications
Kaseb AO
Journal of Hepatocellular Carcinoma 2018, 5:51-54
Published Date: 8 May 2018
Basic MRI for the liver oncologists and surgeons
Vu LN, Morelli JN, Szklaruk J
Journal of Hepatocellular Carcinoma 2018, 5:37-50
Published Date: 10 April 2018
Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
Shaker MK, Montasser IF, Sakr M, Elgharib M, Dabbous HM, Ebada H, El Dorry A, Bahaa M, El Meteini M
Journal of Hepatocellular Carcinoma 2018, 5:29-36
Published Date: 27 February 2018
Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
Najjar M, Agrawal S, Emond JC, Halazun KJ
Journal of Hepatocellular Carcinoma 2018, 5:17-28
Published Date: 18 January 2018
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N
Journal of Hepatocellular Carcinoma 2018, 5:9-15
Published Date: 12 January 2018

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma
Liang B, Yao SY, Zhou JP, Li ZK, Liu TQ
Journal of Hepatocellular Carcinoma 2018, 5:1-7
Published Date: 12 January 2018
Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator
Suryatenggara J, Wibowo H, Atmodjo WL, Mathew G
Journal of Hepatocellular Carcinoma 2017, 4:139-151
Published Date: 28 November 2017

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions
Ray EM, Sanoff HK
Journal of Hepatocellular Carcinoma 2017, 4:131-138
Published Date: 8 November 2017

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
Fateen W, Khan F, O’Neill RJ, James MW, Ryder SD, Aithal GP
Journal of Hepatocellular Carcinoma 2017, 4:123-130
Published Date: 16 October 2017
A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

de la Torre AN, Contractor S, Castaneda I, Cathcart CS, Razdan D, Klyde D, Kisza P, Gonzales SF, Salazar AM
Journal of Hepatocellular Carcinoma 2017, 4:111-121
Published Date: 7 August 2017
Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
Sacco R, Tapete G, Simonetti N, Sellitri R, Natali V, Melissari S, Cabibbo G, Biscaglia L, Bresci G, Giacomelli L
Journal of Hepatocellular Carcinoma 2017, 4:105-110
Published Date: 27 July 2017

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
Galun D, Srdic-Rajic T, Bogdanovic A, Loncar Z, Zuvela M
Journal of Hepatocellular Carcinoma 2017, 4:93-103
Published Date: 11 July 2017

Hepatocellular carcinoma: early-stage management challenges
Erstad DJ, Tanabe KK
Journal of Hepatocellular Carcinoma 2017, 4:81-92
Published Date: 23 June 2017
Screening for hepatocellular carcinoma: patient selection and perspectives
Fateen W, Ryder SD
Journal of Hepatocellular Carcinoma 2017, 4:71-79
Published Date: 17 May 2017

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L
Tarakanovskaya MG, Chinburen J, Batchuluun P, Munkhzaya C, Purevsuren G, Dandii D, Hulan T, Oyungerel D, Kutsyna GA, Reid AA, Borisova V, Bain AI, Jirathitikal V, Bourinbaiar AS
Journal of Hepatocellular Carcinoma 2017, 4:59-69
Published Date: 12 April 2017
Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
Zimmerman A, Grand D, Charpentier KP
Journal of Hepatocellular Carcinoma 2017, 4:49-58
Published Date: 13 March 2017
A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus
Chotirosniramit A, Liwattanakun A, Lapisatepun W, Ko-iam W, Sandhu T, Junrungsee S
Journal of Hepatocellular Carcinoma 2017, 4:41-47
Published Date: 7 March 2017


Liver Imaging Reporting and Data System: an expert consensus statement
Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB
Journal of Hepatocellular Carcinoma 2017, 4:29-39
Published Date: 17 February 2017
Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge
Francica G
Journal of Hepatocellular Carcinoma 2017, 4:23-27
Published Date: 20 January 2017

Pediatric hepatocellular carcinoma: challenges and solutions
Schmid I, von Schweinitz D
Journal of Hepatocellular Carcinoma 2017, 4:15-21
Published Date: 16 January 2017
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
Zhong J, Luo C, Zhang C, Li L
Journal of Hepatocellular Carcinoma 2017, 4:11-13
Published Date: 30 December 2016

Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration
Ma KW, Cheung TT
Journal of Hepatocellular Carcinoma 2017, 4:1-9
Published Date: 28 December 2016
Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date
Pievsky D, Pyrsopoulos N
Journal of Hepatocellular Carcinoma 2016, 3:69-76
Published Date: 15 November 2016
GPC-3 in hepatocellular carcinoma: current perspectives
Wu Y, Liu H, Ding H
Journal of Hepatocellular Carcinoma 2016, 3:63-67
Published Date: 8 November 2016
Minimally invasive image-guided therapies for hepatocellular carcinoma
Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC
Journal of Hepatocellular Carcinoma 2016, 3:55-61
Published Date: 11 October 2016

Hepatocellular carcinoma: a review
Balogh J, Victor III D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour Jr HP
Journal of Hepatocellular Carcinoma 2016, 3:41-53
Published Date: 5 October 2016
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary
Mizejewski GJ
Journal of Hepatocellular Carcinoma 2016, 3:37-40
Published Date: 21 September 2016

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
Trojan J, Waidmann O
Journal of Hepatocellular Carcinoma 2016, 3:31-36
Published Date: 21 September 2016

Transarterial radioembolization for hepatocellular carcinoma: a review
Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S, Eggenhoffner R, Bresci G, Cabibbo G, Giacomelli L
Journal of Hepatocellular Carcinoma 2016, 3:25-29
Published Date: 25 July 2016

Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients
Atta MM, Atta HM, Gad MA, Rashed LA, Said EM, Hassanien SE, Kaseb AO
Journal of Hepatocellular Carcinoma 2016, 3:19-24
Published Date: 14 June 2016

Hepatocellular carcinoma in elderly patients: challenges and solutions
Brunot A, Le Sourd S, Pracht M, Edeline J
Journal of Hepatocellular Carcinoma 2016, 3:9-18
Published Date: 17 June 2016

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO
Journal of Hepatocellular Carcinoma 2016, 3:1-7
Published Date: 5 February 2016

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
Lafaro KJ, Pawlik TM
Journal of Hepatocellular Carcinoma 2015, 2:151-157
Published Date: 9 October 2015


Role of endoscopic ultrasound in diagnosis and management of hepatocellular carcinoma


Koduru P, Suzuki R, Lakhtakia S, Ramchandani M, Makmun D, Bhutani MS
Journal of Hepatocellular Carcinoma 2015, 2:143-149
Published Date: 6 October 2015

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma
Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO
Journal of Hepatocellular Carcinoma 2015, 2:131-142
Published Date: 18 September 2015

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
Jang JH, Lee JW, Hong JT, Jin YJ
Journal of Hepatocellular Carcinoma 2015, 2:123-129
Published Date: 2 September 2015

Whither α-FP in the diagnosis of hepatocellular carcinoma?
Kew MC
Journal of Hepatocellular Carcinoma 2015, 2:119-121
Published Date: 24 August 2015

State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization

Luersen GF, Bhosale P, Szklaruk J
Journal of Hepatocellular Carcinoma 2015, 2:101-117
Published Date: 10 July 2015

The androgen receptor as an emerging target in hepatocellular carcinoma
Kanda T, Yokosuka O
Journal of Hepatocellular Carcinoma 2015, 2:91-99
Published Date: 26 June 2015


Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P
Journal of Hepatocellular Carcinoma 2015, 2:79-89
Published Date: 22 June 2015

Emerging role of Hpo signaling and YAP in hepatocellular carcinoma
Valero V III, Pawlik TM, Anders RA
Journal of Hepatocellular Carcinoma 2015, 2:69-78
Published Date: 18 June 2015

Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy
Gao F, Jing P, Liu J, Lu YF, Zhang PC, Han W, Liu GL, Ru N, Cui GH, Sun CL, Che YB, Zhang HM, Hu QL, Wang HY, Wu YL, Guan CJ, Fu Q, Ma ZL, Yu BF
Journal of Hepatocellular Carcinoma 2015, 2:57-68
Published Date: 9 June 2015

Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields
Beebe SJ
Journal of Hepatocellular Carcinoma 2015, 2:49-55
Published Date: 22 May 2015

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
Lee SH, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH
Journal of Hepatocellular Carcinoma 2015, 2:39-47
Published Date: 28 April 2015

c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
Granito A, Guidetti E, Gramantieri L
Journal of Hepatocellular Carcinoma 2015, 2:29-38
Published Date: 24 April 2015

A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
Cauchy F, Belghiti J
Journal of Hepatocellular Carcinoma 2015, 2:19-27
Published Date: 23 February 2015

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
Yang J, Li M, Zheng QC
Journal of Hepatocellular Carcinoma 2015, 2:11-17
Published Date: 16 February 2015

Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors
Zeeneldin AA, Salem SE, Darwish AD, El-Gammal MM, Hussein MM, Saadeldin M
Journal of Hepatocellular Carcinoma 2015, 2:3-9
Published Date: 30 January 2015

Welcome to Journal of Hepatocellular Carcinoma
Kaseb AO
Journal of Hepatocellular Carcinoma 2015, 2:1-2
Published Date: 9 January 2015

Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy
Bishay VL, Maglione K, Khanna R, Lee KM, Fischman AM, Lookstein RA, Kim E
Journal of Hepatocellular Carcinoma 2014, 1:187-193
Published Date: 27 November 2014

Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
Aiolfi R, Sitia G
Journal of Hepatocellular Carcinoma 2014, 1:183-186
Published Date: 13 November 2014

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
Cappelli A, Pettinato C, Golfieri R
Journal of Hepatocellular Carcinoma 2014, 1:163-182
Published Date: 3 November 2014

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
Braidwood L, Learmonth K, Graham A, Conner J
Journal of Hepatocellular Carcinoma 2014, 1:149-161
Published Date: 16 October 2014

Radiological diagnosis of hepatocellular carcinoma
Bargellini I, Battaglia V, Bozzi E, Lauretti DL, Lorenzoni G, Bartolozzi C
Journal of Hepatocellular Carcinoma 2014, 1:137-148
Published Date: 9 September 2014


Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma


Hsu HT, Chi CW
Journal of Hepatocellular Carcinoma 2014, 1:127-135
Published Date: 26 August 2014

Hepatocellular carcinoma: epidemiology and risk factors
Kew MC
Journal of Hepatocellular Carcinoma 2014, 1:115-125
Published Date: 13 August 2014

Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series
Torres HA, Kaseb A, Mahale P, Miller E, Frenette C
Journal of Hepatocellular Carcinoma 2014, 1:109-114
Published Date: 16 July 2014

Clinical utility of imaging for evaluation of hepatocellular carcinoma
Murakami T, Tsurusaki M, Hyodo T, Imai Y
Journal of Hepatocellular Carcinoma 2014, 1:101-108
Published Date: 14 July 2014

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
Hsu CH, Shen YC, Shao YY, Hsu C, Cheng AL
Journal of Hepatocellular Carcinoma 2014, 1:85-99
Published Date: 12 June 2014


New insights on the role of epigenetic alterations in hepatocellular carcinoma


Frau M, Feo CF, Feo F, Pascale RM
Journal of Hepatocellular Carcinoma 2014, 1:65-83
Published Date: 12 June 2014

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA
Journal of Hepatocellular Carcinoma 2014, 1:55-63
Published Date: 9 June 2014

Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma
Coleman SJ, Grose RP, Kocher HM
Journal of Hepatocellular Carcinoma 2014, 1:43-54
Published Date: 29 May 2014

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
Ofuji K, Saito K, Yoshikawa T, Nakatsura T
Journal of Hepatocellular Carcinoma 2014, 1:35-42
Published Date: 21 May 2014

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
Li L, Diao W, Zen K
Journal of Hepatocellular Carcinoma 2014, 1:21-33
Published Date: 21 May 2014

Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
Akiel M, Rajasekaran D, Gredler R, Siddiq A, Srivastava J, Robertson C, Jariwala NH, Fisher PB, Sarkar D
Journal of Hepatocellular Carcinoma 2014, 1:9-19
Published Date: 26 March 2014

A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors
Shi J, Keller JM, Zhang J, Keller ET
Journal of Hepatocellular Carcinoma 2014, 1:1-7
Published Date: 6 March 2014